GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » GSK PLC (MEX:GSK N) » Definitions » Cyclically Adjusted PB Ratio

GSK (MEX:GSK N) Cyclically Adjusted PB Ratio : 5.53 (As of Jun. 27, 2025)


View and export this data going back to 2003. Start your Free Trial

What is GSK Cyclically Adjusted PB Ratio?

As of today (2025-06-27), GSK's current share price is MXN791.00. GSK's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was MXN143.12. GSK's Cyclically Adjusted PB Ratio for today is 5.53.

The historical rank and industry rank for GSK's Cyclically Adjusted PB Ratio or its related term are showing as below:

MEX:GSK N' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 5.02   Med: 8.16   Max: 12
Current: 5.4

During the past years, GSK's highest Cyclically Adjusted PB Ratio was 12.00. The lowest was 5.02. And the median was 8.16.

MEX:GSK N's Cyclically Adjusted PB Ratio is ranked worse than
84.51% of 749 companies
in the Drug Manufacturers industry
Industry Median: 1.98 vs MEX:GSK N: 5.40

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

GSK's adjusted book value per share data for the three months ended in Mar. 2025 was MXN183.235. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is MXN143.12 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


GSK Cyclically Adjusted PB Ratio Historical Data

The historical data trend for GSK's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GSK Cyclically Adjusted PB Ratio Chart

GSK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.29 8.76 6.76 6.28 5.29

GSK Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.25 6.33 6.15 5.29 5.66

Competitive Comparison of GSK's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - General subindustry, GSK's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


GSK's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, GSK's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where GSK's Cyclically Adjusted PB Ratio falls into.


;
;

GSK Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

GSK's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=791.00/143.12
=5.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GSK's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, GSK's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=183.235/136.1000*136.1000
=183.235

Current CPI (Mar. 2025) = 136.1000.

GSK Quarterly Data

Book Value per Share CPI Adj_Book
201506 85.627 100.100 116.422
201509 72.765 100.200 98.835
201512 67.580 100.400 91.610
201603 35.342 100.400 47.909
201606 7.737 101.000 10.426
201609 1.798 101.500 2.411
201612 14.730 102.200 19.616
201703 20.386 102.700 27.016
201706 9.541 103.500 12.546
201709 16.008 104.300 20.889
201712 -0.903 105.000 -1.170
201803 -0.891 105.100 -1.154
201806 48.454 105.900 62.272
201809 55.622 106.600 71.015
201812 47.324 107.100 60.138
201903 51.854 107.000 65.956
201906 44.097 107.900 55.622
201909 144.139 108.400 180.972
201912 141.250 108.500 177.181
202003 190.909 108.600 239.252
202006 195.666 108.800 244.762
202009 203.691 109.200 253.868
202012 193.841 109.400 241.150
202103 209.436 109.700 259.838
202106 213.301 111.400 260.595
202109 216.475 112.400 262.120
202112 204.046 114.700 242.116
202203 210.974 116.500 246.468
202206 199.483 120.500 225.308
202209 102.516 122.300 114.084
202212 122.938 125.300 133.534
202303 127.622 126.800 136.982
202306 134.170 129.400 141.117
202309 139.606 130.100 146.044
202312 141.401 130.500 147.469
202403 143.138 131.600 148.033
202406 164.250 133.000 168.078
202409 178.823 133.500 182.306
202412 176.657 135.100 177.965
202503 183.235 136.100 183.235

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


GSK  (MEX:GSK N) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


GSK Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of GSK's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


GSK Business Description

Industry
Address
79 New Oxford Street, London, GBR, WC1A 1DG
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.

GSK Headlines

No Headlines